Immunization Strategies against Piscirickettsia salmonis Infections: Review of Vaccination Approaches and Modalities and Their Associated Immune Response Profiles
Open Access
- 18 November 2016
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 7, 482
Abstract
Salmonid rickettsial septicemia is a serious, infectious disease in Chilean salmon farming caused by Piscirickettsia salmonis, causing heavy losses to the salmonid industry. P. salmonis belongs to the Gammaproteobacteria, order Thiotrichales. SRS was first described in Chile in 1989, and infection with P. salmonis has since been described from a high number of fish species and in several geographic regions globally. P. salmonis infection of salmonids causes multifocal, necrotic areas of internal organs like liver, kidney and spleen. Histologically and immunologically the tissue response is formation of granulomas, often with central suppuration. The exact sequence of infection is not known but bacteria likely gain access to internal organs through mucosal surfaces and when infected, fish carry bacteria in macrophages. It has not been fully determined if the bacterium resides in the cytosol or “hide” within vesicular structures intracellularly, although there are indications that in vitro infection results in actin reorganization and formation of actin-coated vesicle within which the bacterium resides. Protection against lethal challenge is well documented in lab scale experiments but protection from vaccination has proven more difficult to attain long term under field conditions. Current vaccination protocols include whole cell, inactivated and adjuvanted vaccines for injection for primary immunization followed by oral boost where timing of boost delivery is followed by measuring circulating antibody levels against the pathogen. Documentation also exist that there is correlation between antibody titers and protection against mortality. Future vaccination regimes will likely also include live, attenuated vaccines or other technologies such as DNA vaccination. So far there is no documentation available for live vaccines and for DNA vaccines, studies have been unsuccessful under laboratory conditions.Keywords
Funding Information
- European Commission (TARGETFISH, grant no. 311993)
This publication has 70 references indexed in Scilit:
- A Novel Liquid Medium for the Efficient Growth of the Salmonid Pathogen Piscirickettsia salmonis and Optimization of Culture ConditionsPLOS ONE, 2013
- Antigen dose and humoral immune response correspond with protection for inactivated infectious pancreatic necrosis virus vaccines in Atlantic salmon (Salmo salar L)Veterinary Research, 2013
- Protective Immunity to Listeria Monocytogenes Infection Mediated by Recombinant Listeria innocua Harboring the VGC LocusPLOS ONE, 2012
- Toll-like receptors in bony fish: From genomics to functionDevelopmental & Comparative Immunology, 2011
- IgT, a primitive immunoglobulin class specialized in mucosal immunityNature Immunology, 2010
- Piscirickettsia salmonis induces apoptosis in macrophages and monocyte‐like cells from rainbow troutJournal of Cellular Biochemistry, 2010
- Productive infection of Piscirickettsia salmonis in macrophages and monocyte‐like cells from rainbow trout, a possible survival strategyJournal of Cellular Biochemistry, 2009
- The use of fish vaccines in the Chilean salmon industry 1999-2003Aquaculture, 2007
- Improved purification of Piscirickettsia salmonis using Percoll gradientsJournal of Microbiological Methods, 2006
- Opsonic effect of rainbow trout (Salmo gairdneri) antibody on phagocytosis of Yersinia ruckeri by trout leukocytesDevelopmental & Comparative Immunology, 1983